Pfizer to spend $120 million to boost US COVID-19 pill manufacturing
The Pfizer logo is seen at the entrance to Pfizer UK headquarters in Tadworth, Britain, December 2, 2020. REUTERS
Pfizer Inc said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up.
Use of the pill, Paxlovid, authorized to treat newly infected, at-risk people to prevent severe illness, has soared recently as infections rise.
Article continues after this advertisement
Biden administration officials have pushed for the wider use of Paxlovid, which the government distributes for free.
FEATURED STORIES
RELATED STORIES
PH gets more than 1 million doses of Pfizer COVID-19 vaccine
Article continues after this advertisementPfizer eyes COVID-19 vaccine for all variants before 2023
780,000 doses of Pfizer COVID-19 vaccine for kids aged 5 – 11 arrive in PHFDA okays use of Pfizer COVID-19 vaccine to children 5-11 years old
Your subscription could not be saved. Please try again.
Your subscription has been successful.
READ NEXT
EDITORS' PICK
